Huiqing et al. [35] reported that MIR92a may promote the proliferation and migration of CRC cells through targeting Krüppel-like factor 4 (KLF4) as well as downstream p21, identified as a negative regulator in cell-cycle progression. The gene discussed is KLF4; the disease is colorectal carcinoma.